BoadieWaidDunlopMD
Psychiatry • Atlanta, GADirector of the Mood and Anxiety Disorders Program (MAP); and Associate Professor of Psychiatry and Behavioral Sciences, Emory University.
Dr. Dunlop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12 Executive Park Dr. NE
3rd Floor
Atlanta, GA 30329Phone+1 404-727-8474Fax+1 404-727-3700
Education & Training
Emory University School of MedicineResidency, Psychiatry, 1997 - 2001
Mayo Clinic College of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 1998 - 2025
NC State Medical License 2020 - 2022- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Thyroid Medication and Antidepressants for Treating Major Depression Start of enrollment: 1996 Sep 01
- Identifying Factors That Predict Antidepressant Treatment Response Start of enrollment: 2006 Aug 01
- Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 44 citationsSingle-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation.Juan Pablo Lopez, Elena Brivio, Alice Santambrogio, Carlo De Donno, Aron Kos
Science Advances. 2021-01-01 - 25 citationsA randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults.Jessica L Maples-Keller, Seth D Norrholm, Mark Burton, Collin Reiff, Callan Coghlan
Journal of Psychopharmacology. 2022-03-01 - 65 citationsInhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).Matthew B. Young, Seth D. Norrholm, Lara M. Khoury, Tanja Jovanovic, Sheila A. M. Rauch
Psychopharmacology. 2017-07-24
Journal Articles
- Response Rate Profiles for Major Depressive Disorder: Characterizing Early Response and Longitudinal NonresponseCharles B Nemeroff, W Edward Craighead, Helen S Mayberg, Boadie W Dunlop, Depression and Anxiety
Authored Content
- F179. Epigenetic Biomarkers in Women with Posttraumatic Stress Disorder After CRF1 Receptor Antagonist TreatmentApril 2018
- F179. Epigenetic Biomarkers in Women with Posttraumatic Stress Disorder After CRF1 Receptor Antagonist TreatmentApril 2018
Press Mentions
SMI Adviser to Bring Hands-on Learning to Annual MeetingMarch 28th, 2023
Emory Looks into Using Psychedelic Drugs as Possible Treatment for DepressionFebruary 13th, 2020
Combining CBT with Antidepressant Found to Be Effective Regardless of OrderMarch 28th, 2019- Join now to see all
Grant Support
- Neural Correlates Of Loss Aversion In Major DepressionNational Institute Of Mental Health2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
